Biodesix
BDSX
58 hedge funds and large institutions have $89.9M invested in Biodesix in 2024 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 10 closing their positions.
3,393% more call options, than puts
Call options by funds: $524K | Put options by funds: $15K
250% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 6
70% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 10
12% more funds holding
Funds holding: 52 → 58 (+6)
0.13% less ownership
Funds ownership: 2.15% → 2.02% (-0.13%)
19% less capital invested
Capital invested by funds: $111M → $89.9M (-$21.2M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
Top Sellers
BDSX Hedge Fund Activity: Q4 2024 in Review
58 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q4 2024, worth a combined $89.9M — down 19% from $111M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new BDSX positions and 10 closed out — a net gain of 7 holders — while 21 added to existing stakes and 6 trimmed.
The largest buyer was Samjo Management, opening a new position worth an estimated $3.64M. The largest seller was Sio Capital Management, exiting entirely with an estimated $7.72M sold.
- 58 institutional investors held Biodesix (BDSX) as of Q4 2024, up from 52 in Q3 2024.
- Funds reported $89.9M of Biodesix stock for Q4 2024, down 19% quarter-over-quarter.
- 17 funds opened new Biodesix positions in Q4 2024 and 10 closed out, a net change of +7 holders.
- The largest Biodesix buyer in Q4 2024 was Samjo Management, an estimated $3.64M added.
- The largest Biodesix seller in Q4 2024 was Sio Capital Management, an estimated $7.72M sold.
Based on aggregated 13F filings for Q4 2024.